Correlation Between Verve Therapeutics and Recursion Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verve Therapeutics and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Verve Therapeutics and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Recursion Pharmaceuticals.

Diversification Opportunities for Verve Therapeutics and Recursion Pharmaceuticals

0.4

Correlation Coefficient

Verve Therapeutics  Recursion Pharmaceuticals

Very weak diversification

The 3 months correlation between Verve and Recursion is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Recursion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Verve Therapeutics and Recursion Pharmaceuticals

Given the investment horizon of 90 days Verve Therapeutics is expected to generate 1.98 times more return on investment than Recursion Pharmaceuticals. However, Verve Therapeutics is 1.98 times more volatile than Recursion Pharmaceuticals. It trades about 0.16 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about 0.05 per unit of risk. If you would invest  478.00  in Verve Therapeutics on April 20, 2025 and sell it today you would earn a total of  613.00  from holding Verve Therapeutics or generate 128.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Verve Therapeutics  vs.  Recursion Pharmaceuticals

Verve Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Verve Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Verve Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Recursion Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Verve Therapeutics and Recursion Pharmaceuticals

The main advantage of trading using opposite Verve Therapeutics and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.

The idea behind Verve Therapeutics and Recursion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.